CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase III Open-label Safety and Immunogenicity Study of GARDASIL™9 Administered to 9- to 26-Year-Old Females and Males in Vietnam

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03546842
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:48.839819+00:00
Published At: 2020-02-05T00:00:00+00:00
Record Updated At: 2020-02-25
Results Posted At: 2020-02-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Papillomavirus Infections", "Uterine Cervical Neoplasms", "Vulvar Neoplasms", "Vaginal Neoplasms", "Adenocarcinoma in Situ", "Condylomata Acuminata"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-02-25"
protocolSection.identificationModule.nctId: "NCT03546842"
protocolSection.identificationModule.officialTitle: "A Phase III Open-label Safety and Immunogenicity Study of GARDASIL\u21229 Administered to 9- to 26-Year-Old Females and Males in Vietnam"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-02-05"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.